Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J SACHS

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
American Journal of Obstetrics and Gynecology|November 15, 2024
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensusHiba J Mustafa, Enaja V Sambatur, Alireza A Shamshirsaz, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
The Lancet. Haematology|October 20, 2023
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 studyAndreas Tiede, Christina Hart, Paul Knöbl, et al.
Blood|June 24, 2021
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopeniaGünalp Uzun, Karina Althaus, Anurag Singh, et al.
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Blood Advances|February 8, 2024
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITPLazaro Gil Gonzalez, Kevin D Won, Zoya Tawhidi, et al.
Vox Sanguinis|August 23, 2023
World human neutrophil antigens investigation surveyBehnaz Bayat, Jonas Lowack, Marie Audrain, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
Haematologica|May 20, 2021
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopeniaKarina Althaus, Peter Möller, Günalp Uzun, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
American Journal of Obstetrics and Gynecology|November 15, 2024
Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensusHiba J Mustafa, Enaja V Sambatur, Alireza A Shamshirsaz, et al.
Haematologica|November 13, 2025
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxisFabius J Pelzer, Ella I Ertekin, Olga Oleshko, et al.
The Lancet. Haematology|October 20, 2023
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 studyAndreas Tiede, Christina Hart, Paul Knöbl, et al.
Blood|June 24, 2021
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopeniaGünalp Uzun, Karina Althaus, Anurag Singh, et al.
German Medical Science : GMS E-Journal|July 1, 2021
Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR)Petra Hoffmüller, Monika Brüggemann, Thomas Eggermann, et al.
Blood Advances|February 8, 2024
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITPLazaro Gil Gonzalez, Kevin D Won, Zoya Tawhidi, et al.
Vox Sanguinis|August 23, 2023
World human neutrophil antigens investigation surveyBehnaz Bayat, Jonas Lowack, Marie Audrain, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
Haematologica|May 20, 2021
Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopeniaKarina Althaus, Peter Möller, Günalp Uzun, et al.
The New England Journal of Medicine|August 8, 2024
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and NewbornKenneth J Moise, Leona E Ling, Dick Oepkes, et al.
Pageof 29